STERIS plc News
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
see moreSTERIS plc Market News
5h
No New Material Developments for STERIS (STE) in Past Week; Stock Holds Steady at $214.40
- STERIS (NYSE: STE) saw no major company-specific news in the past week. Shares are steady near $214.40 amid broader sector trends.
7d
STERIS Unveils Three New Products Including FDA‑Approved VHP™ LTS60 Sterilizer Amid Award Win
STERIS this week launched the FDA‑approved VHP™ LTS60 sterilizer, introduced Verafit™ sterilization bags, and received an industry award—key developments for its Medical Technology segment.
14d
STERIS Wins VA Contract for V‑PRO MAX 2 Sterilizer, Underscoring Government Demand
Steris (STE) secured a federal contract on September 18, 2026, to supply a V‑PRO MAX 2 sterilizer to the VA, signaling steady institutional demand.
21d
Institutional Activity in Steris (NYSE: STE) Highlights Shifts in Investor Sentiment
Recent disclosures show notable adjustments by institutional investors in Steris (STE) shares over the past week. What it means for the stock trend.
28d
STERIS to Present at Morgan Stanley Healthcare Conference: What Investors Should Watch
STERIS (NYSE: STE) will present at the Morgan Stanley Healthcare Conference on Sept. 15. Here’s what the upcoming presentation means for investors.